AJCN 19th International Congress of Nutrition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheatham, C. L
Right arrow Articles by Carlson, S. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheatham, C. L
Right arrow Articles by Carlson, S. E
Agricola
Right arrow Articles by Cheatham, C. L
Right arrow Articles by Carlson, S. E
American Journal of Clinical Nutrition, Vol. 83, No. 6, S1458-1466S, June 2006
© 2006 American Society for Nutrition


Supplement: n–3 Fatty Acids: Recommendations for Therapeutics and Prevention

n–3 Fatty acids and cognitive and visual acuity development: methodologic and conceptual considerations1,2,3,4

Carol L Cheatham, John Colombo and Susan E Carlson

1 From the Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS (CLC and SEC); the Schiefelbusch Institute for Life Span Studies (CLC and JC) and the Department of Psychology (JC), University of Kansas, Lawrence, KS; and the RL Smith Mental Retardation and Developmental Disabilities Research Center, University of Kansas Medical Center, Kansas City, KS (SEC)

ABSTRACT

Several randomized clinical studies in infants born preterm and at term have explored the effects on visual acuity development of postnatal supplementation with various sources of docosahexaenoic acid (DHA). Higher visual acuity after DHA supplementation is a consistent finding in infants born preterm. For infants born at term, the results are less consistent and are better explained by differences in sensitivity of the visual acuity test (electrophysiologic tests being more sensitive than subjective tests) or by differences in the amount of DHA included in the experimental formula. Differences in the sensitivity of the test may also be relevant in discussions of whether the effects of DHA on visual acuity are transient or persistent. A smaller number of studies have attempted to study the effects of DHA on cognitive development. The major focus of this article is to review the types of methods that have been used to evaluate the effects of DHA on cognition and to provide the rationale for measures that are a better conceptual fit. Research is needed 1) to probe the effects of variable DHA exposure on infant and child development, 2) to measure outcomes that better relate to preschool and school-age cognitive function, and 3) to reinforce, and in some cases demonstrate, links between specific infant and preschool measures of cognitive development. We strongly encourage collaborations with developmental cognitive neuroscientists to facilitate these research goals.

Key Words: Cognition • n–3 fatty acids • vision • development • infants • children




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
C. Agostoni, G. V. Zuccotti, G. Radaelli, R. Besana, A. Podesta, A. Sterpa, A. Rottoli, E. Riva, and M. Giovannini
Docosahexaenoic acid supplementation and time at achievement of gross motor milestones in healthy infants: a randomized, prospective, double-blind, placebo-controlled trial
Am. J. Clinical Nutrition, January 1, 2009; 89(1): 64 - 70.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The American Society for Nutrition